• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

线粒体相关候选基因与诊断模型预测迟发性阿尔茨海默病和轻度认知障碍。

Mitochondria-Related Candidate Genes and Diagnostic Model to Predict Late-Onset Alzheimer's Disease and Mild Cognitive Impairment.

机构信息

Department of Neurology and Institute of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Department of Biochemistry and Molecular Cell Biology, Shanghai Key Laboratory for Tumor Microenvironment and Inflammation, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

出版信息

J Alzheimers Dis. 2024;99(s2):S299-S315. doi: 10.3233/JAD-230314.

DOI:10.3233/JAD-230314
PMID:37334608
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11091583/
Abstract

BACKGROUND

Late-onset Alzheimer's disease (LOAD) is the most common type of dementia, but its pathogenesis remains unclear, and there is a lack of simple and convenient early diagnostic markers to predict the occurrence.

OBJECTIVE

Our study aimed to identify diagnostic candidate genes to predict LOAD by machine learning methods.

METHODS

Three publicly available datasets from the Gene Expression Omnibus (GEO) database containing peripheral blood gene expression data for LOAD, mild cognitive impairment (MCI), and controls (CN) were downloaded. Differential expression analysis, the least absolute shrinkage and selection operator (LASSO), and support vector machine recursive feature elimination (SVM-RFE) were used to identify LOAD diagnostic candidate genes. These candidate genes were then validated in the validation group and clinical samples, and a LOAD prediction model was established.

RESULTS

LASSO and SVM-RFE analyses identified 3 mitochondria-related genes (MRGs) as candidate genes, including NDUFA1, NDUFS5, and NDUFB3. In the verification of 3 MRGs, the AUC values showed that NDUFA1, NDUFS5 had better predictability. We also verified the candidate MRGs in MCI groups, the AUC values showed good performance. We then used NDUFA1, NDUFS5 and age to build a LOAD diagnostic model and AUC was 0.723. Results of qRT-PCR experiments with clinical blood samples showed that the three candidate genes were expressed significantly lower in the LOAD and MCI groups when compared to CN.

CONCLUSION

Two mitochondrial-related candidate genes, NDUFA1 and NDUFS5, were identified as diagnostic markers for LOAD and MCI. Combining these two candidate genes with age, a LOAD diagnostic prediction model was successfully constructed.

摘要

背景

迟发性阿尔茨海默病(LOAD)是最常见的痴呆类型,但发病机制尚不清楚,也缺乏简单便捷的早期诊断标志物来预测其发生。

目的

本研究旨在通过机器学习方法鉴定诊断候选基因以预测 LOAD。

方法

从基因表达综合数据库(GEO)中下载了 3 个包含 LOAD、轻度认知障碍(MCI)和对照(CN)外周血基因表达数据的公共数据集。采用差异表达分析、最小绝对收缩和选择算子(LASSO)和支持向量机递归特征消除(SVM-RFE)方法鉴定 LOAD 诊断候选基因。然后在验证组和临床样本中验证这些候选基因,并建立 LOAD 预测模型。

结果

LASSO 和 SVM-RFE 分析确定了 3 个与线粒体相关的基因(MRGs)作为候选基因,包括 NDUFA1、NDUFS5 和 NDUFB3。在对 3 个 MRGs 的验证中,AUC 值表明 NDUFA1、NDUFS5 具有更好的预测能力。我们还在 MCI 组中验证了候选的 MRGs,AUC 值显示出良好的性能。然后,我们使用 NDUFA1、NDUFS5 和年龄构建了 LOAD 诊断模型,AUC 为 0.723。临床血液样本 qRT-PCR 实验结果表明,与 CN 相比,LOAD 和 MCI 组中这 3 个候选基因的表达明显降低。

结论

鉴定出 2 个与线粒体相关的候选基因 NDUFA1 和 NDUFS5 可作为 LOAD 和 MCI 的诊断标志物。将这两个候选基因与年龄相结合,成功构建了 LOAD 诊断预测模型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf7/11091583/dea3fe8cc8e8/jad-99-jad230314-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf7/11091583/96176492da1d/jad-99-jad230314-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf7/11091583/fa7d82de1d86/jad-99-jad230314-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf7/11091583/86d8db75084c/jad-99-jad230314-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf7/11091583/c7f592c68f08/jad-99-jad230314-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf7/11091583/de96ce382b03/jad-99-jad230314-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf7/11091583/87ee55e7cef1/jad-99-jad230314-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf7/11091583/fbef90789299/jad-99-jad230314-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf7/11091583/dea3fe8cc8e8/jad-99-jad230314-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf7/11091583/96176492da1d/jad-99-jad230314-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf7/11091583/fa7d82de1d86/jad-99-jad230314-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf7/11091583/86d8db75084c/jad-99-jad230314-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf7/11091583/c7f592c68f08/jad-99-jad230314-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf7/11091583/de96ce382b03/jad-99-jad230314-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf7/11091583/87ee55e7cef1/jad-99-jad230314-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf7/11091583/fbef90789299/jad-99-jad230314-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf7/11091583/dea3fe8cc8e8/jad-99-jad230314-g008.jpg

相似文献

1
Mitochondria-Related Candidate Genes and Diagnostic Model to Predict Late-Onset Alzheimer's Disease and Mild Cognitive Impairment.线粒体相关候选基因与诊断模型预测迟发性阿尔茨海默病和轻度认知障碍。
J Alzheimers Dis. 2024;99(s2):S299-S315. doi: 10.3233/JAD-230314.
2
Development of a novel immune infiltration-related diagnostic model for Alzheimer's disease using bioinformatic strategies.利用生物信息学策略开发一种新型的阿尔茨海默病免疫浸润相关诊断模型。
Front Immunol. 2023 Jul 20;14:1147501. doi: 10.3389/fimmu.2023.1147501. eCollection 2023.
3
Hybrid multivariate pattern analysis combined with extreme learning machine for Alzheimer's dementia diagnosis using multi-measure rs-fMRI spatial patterns.基于多模态 rs-fMRI 空间模式的混合多元模式分析结合极限学习机在阿尔茨海默病诊断中的应用。
PLoS One. 2019 Feb 22;14(2):e0212582. doi: 10.1371/journal.pone.0212582. eCollection 2019.
4
ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.载脂蛋白E4对轻度认知障碍和阿尔茨海默病自动诊断分类器的影响。
Neuroimage Clin. 2014 Jan 4;4:461-72. doi: 10.1016/j.nicl.2013.12.012. eCollection 2014.
5
A Stable and Scalable Digital Composite Neurocognitive Test for Early Dementia Screening Based on Machine Learning: Model Development and Validation Study.基于机器学习的稳定且可扩展的数字化复合神经认知测试在早期痴呆筛查中的应用:模型的开发与验证研究。
J Med Internet Res. 2023 Dec 1;25:e49147. doi: 10.2196/49147.
6
Recursive Support Vector Machine Biomarker Selection for Alzheimer's Disease.递归支持向量机生物标志物选择阿尔茨海默病。
J Alzheimers Dis. 2021;79(4):1691-1700. doi: 10.3233/JAD-201254.
7
The PANoptosis-related hippocampal molecular subtypes and key biomarkers in Alzheimer's disease patients.阿尔茨海默病患者中与 PANoptosis 相关的海马分子亚型和关键生物标志物。
Sci Rep. 2024 Oct 11;14(1):23851. doi: 10.1038/s41598-024-75377-2.
8
Effects of imaging modalities, brain atlases and feature selection on prediction of Alzheimer's disease.成像模态、脑图谱和特征选择对阿尔茨海默病预测的影响。
J Neurosci Methods. 2015 Dec 30;256:168-83. doi: 10.1016/j.jneumeth.2015.08.020. Epub 2015 Aug 28.
9
Bioinformatics analysis of diagnostic biomarkers for Alzheimer's disease in peripheral blood based on sex differences and support vector machine algorithm.基于性别差异和支持向量机算法的外周血阿尔茨海默病诊断生物标志物的生物信息学分析。
Hereditas. 2022 Oct 4;159(1):38. doi: 10.1186/s41065-022-00252-x.
10
CD163-Mediated Small-Vessel Injury in Alzheimer's Disease: An Exploration from Neuroimaging to Transcriptomics.阿尔茨海默病中 CD163 介导的小血管损伤:从神经影像学到转录组学的探索。
Int J Mol Sci. 2024 Feb 14;25(4):2293. doi: 10.3390/ijms25042293.

引用本文的文献

1
Bioinformatics and experimental validation identify biomarkers for diagnosing Alzheimer's disease.生物信息学与实验验证确定了用于诊断阿尔茨海默病的生物标志物。
Front Aging Neurosci. 2025 Aug 6;17:1566929. doi: 10.3389/fnagi.2025.1566929. eCollection 2025.
2
Homocysteine interferes with Ndufa1 leading to mitochondrial dysfunction through repression of the NAD/Sirt1 pathway in the brain: a possible link between hyperhomocysteinemia and neurodegeneration.同型半胱氨酸通过抑制大脑中的NAD/Sirt1途径干扰Ndufa1,导致线粒体功能障碍:高同型半胱氨酸血症与神经退行性变之间的可能联系。
Cell Death Dis. 2025 Jul 7;16(1):499. doi: 10.1038/s41419-025-07834-3.
3

本文引用的文献

1
Plasma ATN(I) classification and precision pharmacology in Alzheimer's disease.阿尔茨海默病中的血浆ATN(I)分类与精准药理学
Alzheimers Dement. 2023 Oct;19(10):4729-4734. doi: 10.1002/alz.13084. Epub 2023 Apr 20.
2
Plasma p-tau181 and p-tau217 in discriminating PART, AD and other key neuropathologies in older adults.在老年人群中,血浆 p-tau181 和 p-tau217 可用于区分 PART、AD 及其他关键神经病理学特征。
Acta Neuropathol. 2023 Jul;146(1):1-11. doi: 10.1007/s00401-023-02570-4. Epub 2023 Apr 9.
3
Mitochondria Drive Immune Responses in Critical Disease.
Identification of potential biomarkers and mechanisms for keloid disorder based on comprehensive bioinformatics analysis and machine learning algorithms.
基于综合生物信息学分析和机器学习算法的瘢痕疙瘩疾病潜在生物标志物及机制的鉴定
BMC Med Genomics. 2025 Jul 1;18(1):108. doi: 10.1186/s12920-025-02174-9.
4
Beyond Transgenic Mice: Emerging Models and Translational Strategies in Alzheimer's Disease.超越转基因小鼠:阿尔茨海默病的新兴模型与转化策略
Int J Mol Sci. 2025 Jun 10;26(12):5541. doi: 10.3390/ijms26125541.
5
Excessive Alcohol Use as a Risk Factor for Alzheimer's Disease: Epidemiological and Preclinical Evidence.过度饮酒作为阿尔茨海默病的一个风险因素:流行病学和临床前证据。
Adv Exp Med Biol. 2025;1473:211-242. doi: 10.1007/978-3-031-81908-7_10.
6
Development and Validation of the Communities Geriatric Mild Cognitive Impairment Risk Calculator (CGMCI-Risk).社区老年轻度认知障碍风险计算器(CGMCI-Risk)的开发与验证
Healthcare (Basel). 2024 Oct 10;12(20):2015. doi: 10.3390/healthcare12202015.
7
Identification of Autophagy-Related Biomarkers and Diagnostic Model in Alzheimer's Disease.阿尔茨海默病中自噬相关生物标志物的鉴定及诊断模型的建立。
Genes (Basel). 2024 Aug 5;15(8):1027. doi: 10.3390/genes15081027.
8
Identification of Blood Biomarkers Related to Energy Metabolism and Construction of Diagnostic Prediction Model Based on Three Independent Alzheimer's Disease Cohorts.基于三个独立的阿尔茨海默病队列鉴定与能量代谢相关的血液生物标志物并构建诊断预测模型。
J Alzheimers Dis. 2024;100(4):1261-1287. doi: 10.3233/JAD-240301.
9
Mitochondrial Interaction with Serotonin in Neurobiology and Its Implication in Alzheimer's Disease.线粒体在神经生物学中与血清素的相互作用及其在阿尔茨海默病中的意义。
J Alzheimers Dis Rep. 2023 Nov 1;7(1):1165-1177. doi: 10.3233/ADR-230070. eCollection 2023.
线粒体在危重病的免疫反应中起作用。
Cells. 2022 Dec 18;11(24):4113. doi: 10.3390/cells11244113.
4
Synaptic degeneration in Alzheimer disease.阿尔茨海默病中的突触退化
Nat Rev Neurol. 2023 Jan;19(1):19-38. doi: 10.1038/s41582-022-00749-z. Epub 2022 Dec 13.
5
A Clinician's Guide to Bioinformatics for Next-Generation Sequencing.临床医师下一代测序生物信息学指南
J Thorac Oncol. 2023 Feb;18(2):143-157. doi: 10.1016/j.jtho.2022.11.006. Epub 2022 Nov 12.
6
Screening of potential biomarkers in peripheral blood of patients with depression based on weighted gene co-expression network analysis and machine learning algorithms.基于加权基因共表达网络分析和机器学习算法筛选抑郁症患者外周血中的潜在生物标志物
Front Psychiatry. 2022 Oct 17;13:1009911. doi: 10.3389/fpsyt.2022.1009911. eCollection 2022.
7
Composition of the infiltrating immune cells in the brain of healthy individuals: effect of aging.健康个体大脑中浸润性免疫细胞的组成:衰老的影响。
Immun Ageing. 2022 Oct 8;19(1):45. doi: 10.1186/s12979-022-00302-y.
8
Clinical performance and robustness evaluation of plasma amyloid-β prescreening.血浆β淀粉样蛋白预筛查的临床性能及稳健性评估
Alzheimers Dement. 2023 Apr;19(4):1393-1402. doi: 10.1002/alz.12801. Epub 2022 Sep 23.
9
The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's disease.阿尔茨海默病协会关于阿尔茨海默病血液生物标志物的合理使用建议。
Alzheimers Dement. 2022 Dec;18(12):2669-2686. doi: 10.1002/alz.12756. Epub 2022 Jul 31.
10
Hub Genes, Diagnostic Model, and Predicted Drugs Related to Iron Metabolism in Alzheimer's Disease.阿尔茨海默病中与铁代谢相关的枢纽基因、诊断模型及预测药物
Front Aging Neurosci. 2022 Jul 7;14:949083. doi: 10.3389/fnagi.2022.949083. eCollection 2022.